Patient Support and Co-Pay Program
Novartis is proud to support patients through various financial, counseling, and co-pay programs.
Novartis is proud to support patients through various financial, counseling, and co-pay programs.
Novartis Oncology Universal Co-Pay Program
Patients may be eligible for immediate co-pay savings on their next prescription of AFINITOR® (everolimus) Tablets and AFINITOR DISPERZ® (everolimus tablets for oral suspension).
Eligible patients with private insurance may pay $0 per month
Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*
Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.
Patient Assistance Now Oncology
Patient Assistance Now Oncology (PANO) is a support center consisting of insurance specialists and case managers who provide access to information regarding an array of services. Consider PANO your first stop for information about Novartis Oncology Patient Support services. Dedicated support specialists help direct callers to the services that best fit their needs.
Learn more by visiting HCP.Novartis.com/Access or calling 1-800-282-7630
AFINITOR and AFINITOR DISPERZ are contraindicated in patients with hypersensitivity to everolimus, to other rapamycin derivatives, or to any of the excipients...
Advanced HR+, HER2-Negative Breast Cancer
AFINITOR is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole...